CPIX (Cumberland Pharmaceuticals Inc) Stock Analysis - AI Report

Cumberland Pharmaceuticals Inc (CPIX) is a publicly traded Healthcare sector company. As of May 21, 2026, CPIX trades at $5.47 with a market cap of $76.71M and a P/E ratio of -11.37. CPIX moved +0.00% today. Year to date, CPIX is +38.25%; over the trailing twelve months it is +9.94%. Its 52-week range spans $1.04 to $7.25. Rallies surfaces CPIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on CPIX?

Rallies AI research for CPIX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

CPIX Key Metrics

Key financial metrics for CPIX
MetricValue
Price$5.47
Market Cap$76.71M
P/E Ratio-11.37
EPS$-0.49
Dividend Yield0.00%
52-Week High$7.25
52-Week Low$1.04
Volume1.63K
Avg Volume0
Revenue (TTM)$41.94M
Net Income$-7.40M
Gross Margin82.89%

Latest CPIX News

Recent CPIX Insider Trades

  • Young Caroline bought 6 (~$20.7) on Aug 29, 2025.
  • Jones James bought 13 (~$44.85) on Aug 29, 2025.
  • KAZIMI A J bought 13 (~$44.85) on Aug 29, 2025.

CPIX Analyst Consensus

CPIX analyst coverage data. Average price target: $0.00.

Common questions about CPIX

What is the AI research view on CPIX?
Rallies AI research for CPIX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for CPIX?
Rallies AI research for CPIX combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is CPIX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CPIX. It does not provide personalized investment advice.
CPIX

CPIX